These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 36495942)

  • 1. Distinct and overlapping features of nodal peripheral T-cell lymphomas exhibiting a follicular helper T-cell phenotype: a multicenter study emphasizing the clinicopathological significance of follicular helper T-cell marker expression.
    Paik JH; Koh J; Han B; Kim S; Lee KR; Lee S; Lee JO; Kim TM; Kim WY; Jeon YK
    Hum Pathol; 2023 Jan; 131():47-60. PubMed ID: 36495942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological implications of immunohistochemical expression of TBX21, CXCR3, GATA3, CCR4, and TCF1 in nodal follicular helper T-cell lymphoma and peripheral T-cell lymphoma, not otherwise specified.
    Han B; Lim S; Yim J; Song YK; Koh J; Kim S; Lee C; Kim YA; Jeon YK
    J Pathol Transl Med; 2024 Mar; 58(2):59-71. PubMed ID: 38247153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Markers of Follicular Helper T Cells Are Occasionally Expressed in T-Cell or Histiocyte-Rich Large B-Cell Lymphoma, Classic Hodgkin Lymphoma, and Atypical Paracortical HyperplasiaA Diagnostic Pitfall For T-Cell Lymphomas of T Follicular Helper Origin.
    Abukhiran I; Syrbu SI; Holman CJ
    Am J Clin Pathol; 2021 Aug; 156(3):409-426. PubMed ID: 33624021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of clinical, pathological, and genomic characteristics of follicular helper T-cell derived lymphomas.
    Yoon SE; Cho J; Kim YJ; Ko YH; Park WY; Kim SJ; Kim WS
    Exp Hematol Oncol; 2021 May; 10(1):33. PubMed ID: 33990228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of a 5 Marker Panel to the Routine Diagnosis of Peripheral T-Cell Lymphoma With T-Follicular Helper Phenotype.
    Basha BM; Bryant SC; Rech KL; Feldman AL; Vrana JA; Shi M; Reed KA; King RL
    Am J Surg Pathol; 2019 Sep; 43(9):1282-1290. PubMed ID: 31283630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological features of programmed cell death-1 and programmed cell death-ligand-1 expression in the tumor cells and tumor microenvironment of angioimmunoblastic T cell lymphoma and peripheral T cell lymphoma not otherwise specified.
    Kim S; Kwon D; Koh J; Nam SJ; Kim YA; Kim TM; Kim CW; Jeon YK
    Virchows Arch; 2020 Jul; 477(1):131-142. PubMed ID: 32170448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral T-cell lymphomas of follicular T-helper cell derivation with Hodgkin/Reed-Sternberg cells of B-cell lineage: both EBV-positive and EBV-negative variants exist.
    Nicolae A; Pittaluga S; Venkataraman G; Vijnovich-Baron A; Xi L; Raffeld M; Jaffe ES
    Am J Surg Pathol; 2013 Jun; 37(6):816-26. PubMed ID: 23598959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follicular Helper T-Cell-derived Nodal Lymphomas: Study of Histomorphologic, Immunophenotypic, Clinical, and RHOA G17V Mutational Profile.
    Jain S; Goswami A; Lone MR; Ramteke P; Gogia A; Aggarwal M; Viswanathan GK; Kakkar D; Mandal T; Sharma A; Sahoo R; Baldia A; Sharma MC; Bakhshi S; Pramanik R; Dhawan R; Kumar L; Mallick S
    Appl Immunohistochem Mol Morphol; 2023 Mar; 31(3):172-180. PubMed ID: 36806188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary cutaneous peripheral T-cell lymphomas with a T-follicular helper phenotype: an integrative clinical, pathological and molecular case series study.
    Wang L; Rocas D; Dalle S; Sako N; Pelletier L; Martin N; Dupuy A; Tazi N; Balme B; Vergier B; Beylot-Barry M; Carlotti A; Bagot M; Battistella M; Chaby G; Ingen-Housz-Oro S; Gaulard P; Ortonne N
    Br J Dermatol; 2022 Dec; 187(6):970-980. PubMed ID: 35895386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral T-cell lymphoma with a T follicular-helper phenotype: A different entity? Results of the Spanish Real-T study.
    Martín García-Sancho A; Rodríguez-Pinilla SM; Domingo-Domenech E; Climent F; Sánchez-Garcia J; López Jiménez J; García-Cosío Piqueras M; Castellvi J; González AJ; González de Villambrosia S; Gómez Codina J; Navarro B; Rodríguez G; Borrero JJ; Fraga M; Naves A; Baeza L; Córdoba R
    Br J Haematol; 2023 Oct; 203(2):182-193. PubMed ID: 37386897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological Study of 30 Cases of Peripheral T-cell Lymphoma with Hodgkin and Reed-Sternberg-like B-cells from Japan.
    Eladl AE; Satou A; Elsayed AA; Suzuki Y; Kato S; Asano N; Nakamura S
    Am J Surg Pathol; 2017 Apr; 41(4):506-516. PubMed ID: 28125450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive comparison of international prognostic indexes for follicular helper T-cell lymphoma.
    Lee YP; Yoon SE; Cho J; Ko YH; Jo H; Kim SJ; Kim WS
    Ann Hematol; 2022 Jul; 101(7):1535-1543. PubMed ID: 35639152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large cell morphology, CMYC+ tumour cells, and PD-1+ tumour cell/intense PD-L1+ cell reactions are important prognostic factors in nodal peripheral T-cell lymphomas with T follicular helper markers.
    Mihashi Y; Kimura S; Iwasaki H; Oshiro Y; Takamatsu Y; Kawauchi S; Shimajiri S; Ishizuka K; Takeshita M
    Diagn Pathol; 2021 Nov; 16(1):101. PubMed ID: 34742294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of follicular helper T cell markers in nodal peripheral T cell lymphomas: a tissue microarray analysis of 162 cases.
    Zhan HQ; Li XQ; Zhu XZ; Lu HF; Zhou XY; Chen Y
    J Clin Pathol; 2011 Apr; 64(4):319-24. PubMed ID: 21330314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral T-cell lymphoma with follicular T-cell markers.
    Rodríguez-Pinilla SM; Atienza L; Murillo C; Pérez-Rodríguez A; Montes-Moreno S; Roncador G; Pérez-Seoane C; Domínguez P; Camacho FI; Piris MA
    Am J Surg Pathol; 2008 Dec; 32(12):1787-99. PubMed ID: 18779728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of Angioimmunoblastic T-Cell Lymphoma (AITL) and other T Follicular Helper Cell lymphomas (TFH PTCL).
    Ma H; O'Connor OA; Marchi E
    Semin Hematol; 2021 Apr; 58(2):95-102. PubMed ID: 33906727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of clinicopathological and molecular abnormalities of angioimmunoblastic T-cell lymphoma].
    Shi YF; Wang HJ; Liu WP; Mi L; Long MP; Liu YF; Lai YM; Zhou LX; Diao XT; Li XH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Jun; 55(3):521-529. PubMed ID: 37291929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follicular helper T-cell lymphomas: disease spectrum, relationship with clonal hematopoiesis, and mimics. A report of the 2022 EA4HP/SH lymphoma workshop.
    Ondrejka SL; Amador C; Climent F; Ng SB; Soma L; Zamo A; Dirnhofer S; Quintanilla-Martinez L; Wotherspoon A; Leoncini L; de Leval L
    Virchows Arch; 2023 Sep; 483(3):349-365. PubMed ID: 37500795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T follicular helper phenotype predicts response to histone deacetylase inhibitors in relapsed/refractory peripheral T-cell lymphoma.
    Ghione P; Faruque P; Mehta-Shah N; Seshan V; Ozkaya N; Bhaskar S; Yeung J; Spinner MA; Lunning M; Inghirami G; Moskowitz A; Galasso N; Ganesan N; van der Weyden C; Ruan J; Prince HM; Trotman J; Advani R; Dogan A; Horwitz S
    Blood Adv; 2020 Oct; 4(19):4640-4647. PubMed ID: 33002132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of CXCL13 by neoplastic cells in angioimmunoblastic T-cell lymphoma (AITL): a new diagnostic marker providing evidence that AITL derives from follicular helper T cells.
    Dupuis J; Boye K; Martin N; Copie-Bergman C; Plonquet A; Fabiani B; Baglin AC; Haioun C; Delfau-Larue MH; Gaulard P
    Am J Surg Pathol; 2006 Apr; 30(4):490-4. PubMed ID: 16625095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.